Literature DB >> 22263707

Opioid pharmacotherapy in criminal justice settings: now is the time.

Joshua D Lee, Josiah D Rich.   

Abstract

Mesh：

Year:  2012        PMID： 22263707     DOI： 10.1080/08897077.2011.616797

Source DB:  PubMed          Journal:  Subst Abus        ISSN： 0889-7077            Impact factor:   3.716


× No keyword cloud information.
  12 in total

1.  Commentary on "The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible".

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz
Journal:  J Addict Med       Date:  2018 Nov/Dec       Impact factor: 3.702

2.  Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections.

Authors:  Peter D Friedmann; Donna Wilson; Hannah K Knudsen; Lori J Ducharme; Wayne N Welsh; Linda Frisman; Kevin Knight; Hsiu-Ju Lin; Amy James; Carmen E Albizu-Garcia; Jennifer Pankow; Elizabeth A Hall; Terry F Urbine; Sami Abdel-Salam; Jamieson L Duvall; Frank J Vocci
Journal:  J Subst Abuse Treat       Date:  2014-10-14

3.  Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.

Authors:  Shannon Gwin Mitchell; Jennifer Willet; Laura B Monico; Amy James; Danielle S Rudes; Jill Viglione; Robert P Schwartz; Michael S Gordon; Peter D Friedmann
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

4.  Impact of methadone treatment initiated in jail on subsequent arrest.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E O'Grady; Shannon G Mitchell; Tiffany Duren; Anjalee Sharma; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2020-04-04

5.  Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic.

Authors:  Aaron D Fox; Matthew R Anderson; Gary Bartlett; John Valverde; Joanna L Starrels; Chinazo O Cunningham
Journal:  J Health Care Poor Underserved       Date:  2014-08

6.  Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.

Authors:  Joshua D Lee; Peter D Friedmann; Tamara Y Boney; Randall A Hoskinson; Ryan McDonald; Michael Gordon; Marc Fishman; Donna T Chen; Richard J Bonnie; Timothy W Kinlock; Edward V Nunes; James W Cornish; Charles P O'Brien
Journal:  Contemp Clin Trials       Date:  2015-01-17       Impact factor: 2.226

7.  "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.

Authors:  Jeronimo A Maradiaga; Shadi Nahvi; Chinazo O Cunningham; Jennifer Sanchez; Aaron D Fox
Journal:  J Subst Abuse Treat       Date:  2015-11-25

8.  Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.

Authors:  Joshua D Lee; Peter D Friedmann; Timothy W Kinlock; Edward V Nunes; Tamara Y Boney; Randall A Hoskinson; Donna Wilson; Ryan McDonald; John Rotrosen; Marc N Gourevitch; Michael Gordon; Marc Fishman; Donna T Chen; Richard J Bonnie; James W Cornish; Sean M Murphy; Charles P O'Brien
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

9.  Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.

Authors:  Allison G Robertson; Michele M Easter; Hsiu-Ju Lin; Linda K Frisman; Jeffrey W Swanson; Marvin S Swartz
Journal:  J Subst Abuse Treat       Date:  2017-12-12

10.  Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.

Authors:  Jennifer J Carroll; Brandon D L Marshall; Josiah D Rich; Traci C Green
Journal:  Int J Drug Policy       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.